uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

about

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread.Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.

P2860

Q44151258-6D6165CA-D88F-4C34-833E-88FA654AAEF7 Q44390257-73345A1B-E8EE-494B-9AC6-4293BC26A26D

P2860

uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

Item

http://www.wikidata.org/entity/Q40740643

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

uPA-silica-Particles (SP-uPA): ...... potential cancer therapeutics.

@en

type

Item

label

uPA-silica-Particles (SP-uPA): ...... potential cancer therapeutics.

@en

prefLabel

uPA-silica-Particles (SP-uPA): ...... potential cancer therapeutics.

@en

P1476

uPA-silica-Particles (SP-uPA): ...... potential cancer therapeutics

@en

P2093

Alexandra Eickler

http://www.w3.org/2001/XMLSchema#string

Elke Guthaus

http://www.w3.org/2001/XMLSchema#string

Horst Kessler

http://www.w3.org/2001/XMLSchema#string

Manfred Schmitt

http://www.w3.org/2001/XMLSchema#string

Markus Bürgle

http://www.w3.org/2001/XMLSchema#string

Michael D Kramer

http://www.w3.org/2001/XMLSchema#string

Niko Schmiedeberg

http://www.w3.org/2001/XMLSchema#string

Stefan Hocke

http://www.w3.org/2001/XMLSchema#string

Viktor Magdolen

http://www.w3.org/2001/XMLSchema#string

P2860

Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator

Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator.

Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay.

Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer.

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.

Prevention of metastasis by inhibition of the urokinase receptor.

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

P304

207-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/BC.2002.021

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

383

http://www.w3.org/2001/XMLSchema#string

P50

F Sweep

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11930939

http://www.w3.org/2001/XMLSchema#string

uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

about

P2860

P2860

uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698